Myofascial Trigger Point PainNCT07591259
Effect of Integrated Neuromuscular Inhibition Technique on Hand Grip Strength in Upper Trapezius Myofascial Trigger Points
A study testing Integrated Neuromuscular Inhibition Technique and Conventional Physical Therapy in people with Myofascial Trigger Point Pain, run by Cairo University at 1 site in Egypt.
Trial summary
This study aims to investigate the effects of the integrated neuromuscular inhibition technique on patients with upper trapezius myofascial trigger points by evaluating its impact on neck pain intensity, pressure pain threshold, hand grip strength, pinch grip strength, wrist joint range of motion, and upper extremity… Read more about this study
- Who is it for?
- Ages 18 to 55 years
- Conditions the study is for
- Myofascial Trigger Point Pain
- What is being tested?
- Integrated Neuromuscular Inhibition Technique and Conventional Physical Therapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 15 May 2026to 15 Aug 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Subjects will be selected from out patient clinic of Delta University hospital, Dakahlia, Egypt.
- Subjects aged between 18 and 55 years.
- Their body mass index (BMI) were ranged from 18-30 kg/m2.
- Subjects diagnosed as myofascial pain syndrome with a unilateral upper trapezius myofascial trigger point on the dominant side by a physician.
- Subjects must have characteristics of trigger points: hardened, thickened taut bands in MPS patients. Contraction knots within taut muscle bands are pathognomonic features of MTrPs. Common features of the trigger point include the tender bands of muscles, taut band which could produce pain while pressing it directly or sometimes spontaneous, with this there was weak muscles, sensory motor dysfunctions, changes in motor control function and disruption of normal patterns of motor recruitments are seen.
- Subjects from both genders.
- The severity of pain on the visual analogue scale should be higher than two out of ten.
- Patients will receive all standard medical treatment.
Who cannot join
- A history of any major neurological or musculoskeletal disorders, cardiovascular or respiratory diseases.
- Neck pain due to cervical spine pathology.
- Any history of cervical trauma, fractures or dislocations, carcinoma.
- Uncooperative behavior, and unwillingness to participate.
- Wrist problems (stiffness, fracture, operation or carpal tunnel syndrome).
Trial locations and contacts
1 site in 1 country.
About this study
This study aims to investigate the effects of the integrated neuromuscular inhibition technique on patients with upper trapezius myofascial trigger points by evaluating its impact on neck pain intensity, pressure pain threshold, hand grip strength, pinch grip strength, wrist joint range of motion, and upper extremity function.
Read the detailed description
Myofascial pain syndrome (MPS) is one of the most common musculoskeletal disorders. Approximately, 30% to 85% of the population with musculoskeletal disorders would experience Myofascial trigger points (MTrPs) in their life. Also, the prevalence of MTrP has been reported as 21%, 30%, and 93% in the patients of a general orthopedic clinic.
Myofascial trigger points (MTrPs) are hypersensitive, cord-like or nodular tender spots found in a skeletal muscle. They are painful on palpation, compression or stretch. The prevalence of affection of these trigger points have found to be more in postural muscles such as the trapezius. It has been found that 85% of people who come to pain clinics show presence of trigger points in the neck, and that occurs more commonly in women than men.
The trigger point sites in the upper trapezius commonly refer pain along the posterolateral aspect of the neck, behind the ear to the temple. MTrP in the upper trapezius is known to usually present with complains of neck pain, headache, muscle stiffness, restricted range of motion (ROM) of the cervical joint, and insomnia by the patient. It is frequently caused by poor posture, acute trauma, muscle stress, and psychological stress.
The trapezius muscle has a supporting and stabilizing function on the movement of the upper extremities, such as in many everyday work tasks (computer work, cleaning, eating). The trapezius muscle is involved in many activities related to the high prevalence of neck pain. This muscle participates in long-term low-level activity, which is typically appreciated by office workers. Tightness of the upper trapezius lead to muscle imbalance in the scapulothoracic region, leading to neck pain and cervicogenic headaches.
The most important functions of the upper extremity for independent and smooth activities of daily living are the functions of the hand. A representative function of the hand is to hold something. The strength of the fingers when holding something is known as grip strength and it is an important index in the evaluation of motor function of the hand.
It is widely accepted that grip strength provides an objective index of the functional integrity of the upper extremity. Physical and occupational therapists commonly measure grip strength to monitor the success or failure of their treatment programs, besides, grip strength serves to be an important contributor to quality of life, functional ability, and independence.
A previous study has revealed the effectiveness of conventional treatment in reducing neck pain in patients with upper trapezius trigger points. Stretching techniques, Myofascial release, proprioceptive neuromuscular facilitation, and ischemic compression are a few types of manual therapy. Applying massage therapy to the sensitive region is one of the treatment modalities that patients choose in addition to their therapies for greater relaxation.
Integrated neuromuscular inhibition (INI) has also been proposed to alleviate neck pain, improve cervical range of motion, and eliminate neck dysfunction. INI has been approved as an efficient treatment for MTrPs, allowing the use of the three techniques in a single and coordinated manner. It was suggested that combination of Muscle energy technique (MET), ischemic compression and Strain Counter-strain (SCS) producing a most effective, targeted approach to TrP release. This method is termed as integrated neuromuscular inhibition technique (INIT). The benefit of the technique lies in its multifaceted approach allowing delivery of the techniques in a single coordinated manner.
Neuromuscular Inhibition Technique (INIT) has gained attention for its potential efficacy in deactivating MTrPs and enhancing musculoskeletal function. It was revealed that results with INIT in reducing pain and improving function in patients with upper trapezius MTrPs. For instance, a previous study has demonstrated that a single session of INIT significantly lowered pain intensity and pressure pain threshold in individuals with chronic neck pain.
There is a gap in the literature regarding the effect of integrated neuromuscular inhibition technique on hand grip strength in upper trapezius trigger points.
So, this study will conduct to discuss the effect of integrated neuromuscular inhibition technique on neck pain intensity level, pressure pain threshold (PPT), hand grip strength, pinch grip strength, wrist joint range of motion, and upper extremity function in upper trapezius myofascial trigger points.
- Conditions
- Myofascial Trigger Point Pain
- Being tested
- Integrated Neuromuscular Inhibition Technique, Conventional Physical Therapy
- Medical subject headings
- Myofascial Pain Syndromes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Integrated Neuromuscular Inhibition TechniqueOther
Participants in the experimental group will receive the integrated neuromuscular inhibition technique three times per week for four consecutive weeks. The integrated neuromuscular inhibition technique protocol will include ischemic compression, strain-counterstrain (SCS), and muscle energy technique (MET).
Conventional Physical TherapyOther
Participants in the two groups will receive conventional physical therapy three times per week for four consecutive weeks. It consists of deep transverse friction massage (DTFM), passive stretching, and isometric strengthening exercises for the neck muscles.
| Study group | Role | What they receive |
|---|---|---|
| Integrated Neuromuscular Inhibition Technique + Conventional Physical Therapy | Experimental | It will consist of 30 participants who will receive the integrated neuromuscular inhibition technique, including muscle energy techniques (MET), ischemic compression (IC), and strain-counterstrain (SCS), in addition to conventional physical therapy consisting of deep friction massage, passive stretching, and isometric strengthening exercises for the neck muscles. All participants will receive 12 treatment sessions, conducted three times weekly over a period of four weeks. Receives: Other: Integrated Neuromuscular Inhibition Technique; Other: Conventional Physical Therapy |
| Conventional Physical Therapy | Active comparator | It will consist of 30 participants who will receive conventional physical therapy only, including deep friction massage, passive stretching, and isometric strengthening exercises for the neck muscles. All participants will receive 12 treatment sessions, conducted three times weekly over a period of four weeks. Receives: Other: Conventional Physical Therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hand Grip Strength assessment
Hand grip strength will be assessed using a Baseline Digital Hand Dynamometer following the standardized guidelines of the American Society of Hand Therapists (ASHT). Participants will be seated comfortably with back support, shoulders abducted, elbows flexed to 90°, and forearms and wrists maintained in a neutral position. The contralateral hand will rest on the thigh during testing. Participants will be instructed to grip the dynamometer maximally for approximately 3 seconds after one practice trial for each hand. Grip strength values will be recorded in kilograms using the same device throughout the study.
Measured: 4 weeks
Pinch Grip Strength assessment
Pinch grip strength will be assessed using a Baseline Digital Pinch Dynamometer according to the standardized posture recommended by the American Society of Hand Therapists (ASHT). Participants will be seated comfortably with the back straight and feet fully supported on the floor. The shoulders will remain stable without rotation, the elbow will be flexed to 90°, and the forearm will be maintained in a neutral position. The wrist will be positioned between 0-30° of extension and 15° of ulnar deviation, with the arm unsupported by the chair handle during testing.
Measured: 4 weeks
Wrist Range of Motion assessment
It will be assessed by using Digital Goniometer. A goniometer was placed at the ulnar styloid next to the little finger and set the initial state as the zero-degree position for wrist flexion and extension measurements. The radial deviation and ulnar deviation were measured by placing the goniometer at the center of the hand and in the middle of the middle finger.
Measured: 4 weeks
Secondary outcomes (3)
Pain Intensity Level assessment
Pain intensity level will be assessed using the Visual Analog Scale (VAS). Participants will be asked to mark a point on a 100 mm horizontal line that best represents their pain intensity. The examiner will measure the distance in millimeters from the "no pain" anchor to the marked point using a ruler, yielding a score ranging from 0 to 100.
Measured: 4 weeks
Pressure Pain Threshold assessment
Pressure pain threshold will be assessed using a pressure algometer. Participants will be positioned comfortably, and the upper trapezius trigger point will be identified by palpation. Gradual vertical pressure will be applied at a rate of 1 kg/sec until slight discomfort is reported by the participant. The procedure will be repeated three times with 30-second rest intervals, and the mean value will be calculated as the pressure pain threshold. The pressure algometer is considered a reliable assessment tool for pressure pain threshold measurement.
Measured: 4 weeks
Upper Extremity Function assessment
Upper extremity function will be assessed using the Quick Disabilities of the Arm, Shoulder, and Hand questionnaire (QuickDASH). The questionnaire consists of 11 items scored on a five-point Likert scale, with total scores ranging from 0 to 100, where higher scores indicate greater disability. Item scores will be summed, averaged, and transformed into the final score according to the standardized scoring method. Scores below 15 will indicate minimal symptoms, whereas scores above 40 will reflect marked functional limitation and reduced work ability due to upper limb dysfunction.
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 May 2026
- Study start15 May 2026
- Primary completion15 Aug 2026
- Study completion15 Aug 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Myofascial Trigger Point PainStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nouran Ali El-Metwally Ali El-Agamy, Cairo University
- Investigators
- Rania Reda Mohamed, PhD, Study chair, Ass. Prof, Cairo universityHoda Ibrahim Abbas, PhD, Study director, Lecturer, Cairo universityAmr Abdalla Azzam, PhD, Study director, Consultant, National Institute of Neuromotor System
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07591259
- Sponsor's protocol ID
- P.T.REC/012/006407
- Status last verified
- Aug 2026
- First submitted
- 9 May 2026
- Last updated
- 21 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Integrated Neuromuscular Inhibition Technique on Hand Grip Strength in Upper Trapezius Myofascial Trigger Points
- ClinicalTrials.gov ID
- NCT07591259
- Acronym / sponsor ID
- P.T.REC/012/006407
- Conditions
- Myofascial Trigger Point Pain
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 15 May 2026 (actual)
- Primary completion
- 15 Aug 2026 (actual)
- Study completion
- 15 Aug 2026 (actual)
- First posted
- 15 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate the effects of the integrated neuromuscular inhibition technique on patients with upper trapezius myofascial trigger points by evaluating its impact on neck pain intensity, pressure pain threshold, hand grip strength, pinch grip strength, wrist joint range of motion, and upper extremity function.
Detailed description
Myofascial pain syndrome (MPS) is one of the most common musculoskeletal disorders. Approximately, 30% to 85% of the population with musculoskeletal disorders would experience Myofascial trigger points (MTrPs) in their life. Also, the prevalence of MTrP has been reported as 21%, 30%, and 93% in the patients of a general orthopedic clinic.
Myofascial trigger points (MTrPs) are hypersensitive, cord-like or nodular tender spots found in a skeletal muscle. They are painful on palpation, compression or stretch. The prevalence of affection of these trigger points have found to be more in postural muscles such as the trapezius. It has been found that 85% of people who come to pain clinics show presence of trigger points in the neck, and that occurs more commonly in women than men.
The trigger point sites in the upper trapezius commonly refer pain along the posterolateral aspect of the neck, behind the ear to the temple. MTrP in the upper trapezius is known to usually present with complains of neck pain, headache, muscle stiffness, restricted range of motion (ROM) of the cervical joint, and insomnia by the patient. It is frequently caused by poor posture, acute trauma, muscle stress, and psychological stress.
The trapezius muscle has a supporting and stabilizing function on the movement of the upper extremities, such as in many everyday work tasks (computer work, cleaning, eating). The trapezius muscle is involved in many activities related to the high prevalence of neck pain. This muscle participates in long-term low-level activity, which is typically appreciated by office workers. Tightness of the upper trapezius lead to muscle imbalance in the scapulothoracic region, leading to neck pain and cervicogenic headaches.
The most important functions of the upper extremity for independent and smooth activities of daily living are the functions of the hand. A representative function of the hand is to hold something. The strength of the fingers when holding something is known as grip strength and it is an important index in the evaluation of motor function of the hand.
It is widely accepted that grip strength provides an objective index of the functional integrity of the upper extremity. Physical and occupational therapists commonly measure grip strength to monitor the success or failure of their treatment programs, besides, grip strength serves to be an important contributor to quality of life, functional ability, and independence.
A previous study has revealed the effectiveness of conventional treatment in reducing neck pain in patients with upper trapezius trigger points. Stretching techniques, Myofascial release, proprioceptive neuromuscular facilitation, and ischemic compression are a few types of manual therapy. Applying massage therapy to the sensitive region is one of the treatment modalities that patients choose in addition to their therapies for greater relaxation.
Integrated neuromuscular inhibition (INI) has also been proposed to alleviate neck pain, improve cervical range of motion, and eliminate neck dysfunction. INI has been approved as an efficient treatment for MTrPs, allowing the use of the three techniques in a single and coordinated manner. It was suggested that combination of Muscle energy technique (MET), ischemic compression and Strain Counter-strain (SCS) producing a most effective, targeted approach to TrP release. This method is termed as integrated neuromuscular inhibition technique (INIT). The benefit of the technique lies in its multifaceted approach allowing delivery of the techniques in a single coordinated manner.
Neuromuscular Inhibition Technique (INIT) has gained attention for its potential efficacy in deactivating MTrPs and enhancing musculoskeletal function. It was revealed that results with INIT in reducing pain and improving function in patients with upper trapezius MTrPs. For instance, a previous study has demonstrated that a single session of INIT significantly lowered pain intensity and pressure pain threshold in individuals with chronic neck pain.
There is a gap in the literature regarding the effect of integrated neuromuscular inhibition technique on hand grip strength in upper trapezius trigger points.
So, this study will conduct to discuss the effect of integrated neuromuscular inhibition technique on neck pain intensity level, pressure pain threshold (PPT), hand grip strength, pinch grip strength, wrist joint range of motion, and upper extremity function in upper trapezius myofascial trigger points.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Integrated Neuromuscular Inhibition Technique + Conventional Physical Therapy | Experimental | Other: Integrated Neuromuscular Inhibition Technique, Other: Conventional Physical TherapyIt will consist of 30 participants who will receive the integrated neuromuscular inhibition technique, including muscle energy techniques (MET), ischemic compression (IC), and strain-counterstrain (SCS), in addition to conventional physical therapy consisting of deep friction massage, passive stretching, and isometric strengthening exercises for the neck muscles. All participants will receive 12 treatment sessions, conducted three times weekly over a period of four weeks. |
| Conventional Physical Therapy | Active comparator | Other: Conventional Physical TherapyIt will consist of 30 participants who will receive conventional physical therapy only, including deep friction massage, passive stretching, and isometric strengthening exercises for the neck muscles. All participants will receive 12 treatment sessions, conducted three times weekly over a period of four weeks. |
Who may qualify
- Ages
- 18 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- Subjects will be selected from out patient clinic of Delta University hospital, Dakahlia, Egypt.
- Subjects aged between 18 and 55 years.
- Their body mass index (BMI) were ranged from 18-30 kg/m2.
- Subjects diagnosed as myofascial pain syndrome with a unilateral upper trapezius myofascial trigger point on the dominant side by a physician.
- Subjects must have characteristics of trigger points: hardened, thickened taut bands in MPS patients. Contraction knots within taut muscle bands are pathognomonic features of MTrPs. Common features of the trigger point include the tender bands of muscles, taut band which could produce pain while pressing it directly or sometimes spontaneous, with this there was weak muscles, sensory motor dysfunctions, changes in motor control function and disruption of normal patterns of motor recruitments are seen.
Key exclusion criteria (5 listed)
- A history of any major neurological or musculoskeletal disorders, cardiovascular or respiratory diseases.
- Neck pain due to cervical spine pathology.
- Any history of cervical trauma, fractures or dislocations, carcinoma.
- Uncooperative behavior, and unwillingness to participate.
- Wrist problems (stiffness, fracture, operation or carpal tunnel syndrome).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Integrated Neuromuscular Inhibition TechniqueParticipants in the experimental group will receive the integrated neuromuscular inhibition technique three times per week for four consecutive weeks. The integrated neuromuscular inhibition technique protocol will include ischemic compression, strain-counterstrain (SCS), and muscle energy technique (MET). | Other | Integrated Neuromuscular Inhibition Technique + Conventional Physical Therapy |
| Conventional Physical TherapyParticipants in the two groups will receive conventional physical therapy three times per week for four consecutive weeks. It consists of deep transverse friction massage (DTFM), passive stretching, and isometric strengthening exercises for the neck muscles. | Other | Conventional Physical Therapy, Integrated Neuromuscular Inhibition Technique + Conventional Physical Therapy |
Primary outcome
Hand Grip Strength assessment
Time frame: 4 weeks
Hand grip strength will be assessed using a Baseline Digital Hand Dynamometer following the standardized guidelines of the American Society of Hand Therapists (ASHT). Participants will be seated comfortably with back support, shoulders abducted, elbows flexed to 90°, and forearms and wrists maintained in a neutral position. The contralateral hand will rest on the thigh during testing. Participants will be instructed to grip the dynamometer maximally for approximately 3 seconds after one practice trial for each hand. Grip strength values will be recorded in kilograms using the same device throughout the study.
Pinch Grip Strength assessment
Time frame: 4 weeks
Pinch grip strength will be assessed using a Baseline Digital Pinch Dynamometer according to the standardized posture recommended by the American Society of Hand Therapists (ASHT). Participants will be seated comfortably with the back straight and feet fully supported on the floor. The shoulders will remain stable without rotation, the elbow will be flexed to 90°, and the forearm will be maintained in a neutral position. The wrist will be positioned between 0-30° of extension and 15° of ulnar deviation, with the arm unsupported by the chair handle during testing.
Wrist Range of Motion assessment
Time frame: 4 weeks
It will be assessed by using Digital Goniometer. A goniometer was placed at the ulnar styloid next to the little finger and set the initial state as the zero-degree position for wrist flexion and extension measurements. The radial deviation and ulnar deviation were measured by placing the goniometer at the center of the hand and in the middle of the middle finger.
3 secondary outcomes
Pain Intensity Level assessment
Time frame: 4 weeks
Pressure Pain Threshold assessment
Time frame: 4 weeks
Upper Extremity Function assessment
Time frame: 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Aug 2026.
Related trials for Myofascial Trigger Point Pain
Not yet recruiting
Effects of IASTM, Deep Friction Massage, and Sham Instrument-Assisted Soft Tissue Mobilization on Electromyographical Activation, Pain and Function in Non-Specific Low Back Pain
Low Back Pain, Trigger Point Pain, Myofascial
Recruiting
Comparing Myofascial Exercise and Trigger Point Therapy for Non-Specific Low Back Pain
Non-specific Low Back Pain
Recruiting
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome
Myofacial Pain, Myofacial Pain Syndrome
Not yet recruiting
Focused Versus Multi-Target Trigger Point Injection for Chronic Myofascial Neck Pain
Myofacial Pain Syndrome, Chronic Neck Pain
Not yet recruiting
Comparison of Suboccipital Release and Muscle Energy Technique in Subjects With Mechanical Neck Pain and Forward Head Posture
Myofascial Trigger Points, Neck Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Rania Reda Mohamed, PhD study chair
Ass. Prof, Cairo university
Hoda Ibrahim Abbas, PhD study director
Lecturer, Cairo university
Amr Abdalla Azzam, PhD study director
Consultant, National Institute of Neuromotor System
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Integrated Neuromuscular Inhibition Technique and Conventional Physical Therapy in people with Myofascial Trigger Point Pain, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hand Grip Strength assessment (time frame: 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.